Nutriband Inc (NAS:NTRB)
$ 5.1 0.33 (6.92%) Market Cap: 55.95 Mil Enterprise Value: 55.70 Mil PE Ratio: 0 PB Ratio: 7.02 GF Score: 71/100

Nutriband Inc at Emerging Growth Conference Transcript

May 25, 2022 / 06:00PM GMT
Release Date Price: $4.07 (+8.20%)
Ana Berry
Emerging Growth Conference - Moderator

Welcome back, everyone. Our next presenter is Nutriband Inc. It trades on the NASDAQ under the symbol NTRB. It also has warrants that trade on the NASDAQ under the symbol NTRBW.

It is primarily engaged in the development of a portfolio of transdermal pharmaceutical products. Their lead product under development is an abuse deterrent fentanyl patch incorporating are AVERSA abuse deterrent technology.

Joining us today is our CEO, Gareth Sheridan. Welcome, Gareth.

Gareth Sheridan
Nutriband Inc. - CEO

Hey, Ana. Thanks for having me on.

Questions & Answers

Ana Berry
Emerging Growth Conference - Moderator

All right. We're excited to hear a little bit about your company. Tell us about it. Where did it start? And where are you now?

Gareth Sheridan
Nutriband Inc. - CEO

Yes. So Nutriband is a pharmaceutical company with a specific focus on transdermal technologies. Transdermal, for anybody

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot